Reboxetine

Reboxetine is an antidepressant drug used to treat clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine. It is grouped under the following drug class(es): Psychotropic agents. Its therapeutic use is listed as antidepressants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Edronax, Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]- and (2R)-rel-. Its PubChem CID is 127151.